InvestorsHub Logo
Followers 22
Posts 1671
Boards Moderated 0
Alias Born 12/12/2006

Re: biomanbaba post# 4989

Friday, 11/16/2012 4:09:25 PM

Friday, November 16, 2012 4:09:25 PM

Post# of 16750
Listening today to MT's presentation on Lazard's conference, at around 04:14 timing mark, he reiterated the blockbuster potential of the platform. Additionally several key points worth mentioning:

1. Market potential : top of the charts for any oncology treatment
2. Blockbuster potential (can't help repeat smile )
3. Relatively safer & easy pathway for FDA approval due to SPA/505(b) etc
4. China - First to submit with no reference approval required
5. HCC cases: 750k worldwide growing 5% every year. By 2020, it will be #1 cancer surpassing lung cancer

Lastly, MT, mentioned dose dependent PFS increase as much by a factor of 6 !

I bet the conference attendees must be excited as h*ll smile